Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone

A 72-year-old Japanese woman with rheumatoid arthritis whose activity decreased with previous treatments had recurrent thunderclap headaches during an atovaquone regimen for the treatment of pneumocystis pneumonia. The recurrent headaches disappeared after discontinuation of the drug. Brain magnetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Makino, Takahiro, Kamitsukasa, Ikuo, Ito, Shoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803701/
https://www.ncbi.nlm.nih.gov/pubmed/29422854
http://dx.doi.org/10.1159/000484551
_version_ 1783298698184228864
author Makino, Takahiro
Kamitsukasa, Ikuo
Ito, Shoichi
author_facet Makino, Takahiro
Kamitsukasa, Ikuo
Ito, Shoichi
author_sort Makino, Takahiro
collection PubMed
description A 72-year-old Japanese woman with rheumatoid arthritis whose activity decreased with previous treatments had recurrent thunderclap headaches during an atovaquone regimen for the treatment of pneumocystis pneumonia. The recurrent headaches disappeared after discontinuation of the drug. Brain magnetic resonance images showed multiple cerebral vasoconstrictions of cerebral arteries with vasogenic cerebral white matter edema, which diminished several weeks later. We diagnosed the patient's headaches as reversible cerebral vasoconstriction syndrome due to atovaquone.
format Online
Article
Text
id pubmed-5803701
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-58037012018-02-08 Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone Makino, Takahiro Kamitsukasa, Ikuo Ito, Shoichi Case Rep Neurol Case Report A 72-year-old Japanese woman with rheumatoid arthritis whose activity decreased with previous treatments had recurrent thunderclap headaches during an atovaquone regimen for the treatment of pneumocystis pneumonia. The recurrent headaches disappeared after discontinuation of the drug. Brain magnetic resonance images showed multiple cerebral vasoconstrictions of cerebral arteries with vasogenic cerebral white matter edema, which diminished several weeks later. We diagnosed the patient's headaches as reversible cerebral vasoconstriction syndrome due to atovaquone. S. Karger AG 2017-12-19 /pmc/articles/PMC5803701/ /pubmed/29422854 http://dx.doi.org/10.1159/000484551 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Makino, Takahiro
Kamitsukasa, Ikuo
Ito, Shoichi
Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone
title Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone
title_full Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone
title_fullStr Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone
title_full_unstemmed Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone
title_short Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone
title_sort reversible cerebral vasoconstriction syndrome due to atovaquone
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803701/
https://www.ncbi.nlm.nih.gov/pubmed/29422854
http://dx.doi.org/10.1159/000484551
work_keys_str_mv AT makinotakahiro reversiblecerebralvasoconstrictionsyndromeduetoatovaquone
AT kamitsukasaikuo reversiblecerebralvasoconstrictionsyndromeduetoatovaquone
AT itoshoichi reversiblecerebralvasoconstrictionsyndromeduetoatovaquone

Ejemplares similares